nodes	percent_of_prediction	percent_of_DWPC	metapath
Mirabegron—ORM1—Vemurafenib—melanoma	0.219	0.441	CbGbCtD
Mirabegron—ALB—melanoma	0.198	0.512	CbGaD
Mirabegron—ABCB1—melanoma	0.189	0.488	CbGaD
Mirabegron—ALB—Vemurafenib—melanoma	0.0923	0.186	CbGbCtD
Mirabegron—CYP3A4—Temozolomide—melanoma	0.0528	0.106	CbGbCtD
Mirabegron—CYP2D6—Vemurafenib—melanoma	0.0455	0.0914	CbGbCtD
Mirabegron—ABCB1—Dactinomycin—melanoma	0.0321	0.0645	CbGbCtD
Mirabegron—CYP3A4—Vemurafenib—melanoma	0.0289	0.0581	CbGbCtD
Mirabegron—ABCB1—Docetaxel—melanoma	0.0166	0.0333	CbGbCtD
Mirabegron—CYP3A4—Docetaxel—melanoma	0.00993	0.02	CbGbCtD
Mirabegron—Rash papular—Vemurafenib—melanoma	0.0052	0.0613	CcSEcCtD
Mirabegron—Lung neoplasm malignant—Docetaxel—melanoma	0.00328	0.0387	CcSEcCtD
Mirabegron—Gamma-glutamyltransferase increased—Vemurafenib—melanoma	0.00235	0.0277	CcSEcCtD
Mirabegron—Breast cancer—Docetaxel—melanoma	0.0018	0.0213	CcSEcCtD
Mirabegron—Neoplasm—Vemurafenib—melanoma	0.00175	0.0206	CcSEcCtD
Mirabegron—Atrial fibrillation—Vemurafenib—melanoma	0.00148	0.0175	CcSEcCtD
Mirabegron—Gamma-glutamyltransferase increased—Temozolomide—melanoma	0.0012	0.0142	CcSEcCtD
Mirabegron—Cystitis noninfective—Bleomycin—melanoma	0.00115	0.0135	CcSEcCtD
Mirabegron—Cystitis—Bleomycin—melanoma	0.00113	0.0134	CcSEcCtD
Mirabegron—Infestation NOS—Vemurafenib—melanoma	0.00108	0.0128	CcSEcCtD
Mirabegron—Infestation—Vemurafenib—melanoma	0.00108	0.0128	CcSEcCtD
Mirabegron—Stevens-Johnson syndrome—Vemurafenib—melanoma	0.00107	0.0127	CcSEcCtD
Mirabegron—Bladder pain—Bleomycin—melanoma	0.00106	0.0125	CcSEcCtD
Mirabegron—Connective tissue disorder—Vemurafenib—melanoma	0.000956	0.0113	CcSEcCtD
Mirabegron—Vaginal infection—Temozolomide—melanoma	0.000935	0.011	CcSEcCtD
Mirabegron—Neoplasm—Carmustine—melanoma	0.000926	0.0109	CcSEcCtD
Mirabegron—Erythema multiforme—Vemurafenib—melanoma	0.00092	0.0108	CcSEcCtD
Mirabegron—Dry eye—Temozolomide—melanoma	0.000914	0.0108	CcSEcCtD
Mirabegron—Eye disorder—Vemurafenib—melanoma	0.000909	0.0107	CcSEcCtD
Mirabegron—Cardiac disorder—Vemurafenib—melanoma	0.000903	0.0106	CcSEcCtD
Mirabegron—Neoplasm—Temozolomide—melanoma	0.000895	0.0105	CcSEcCtD
Mirabegron—Cerebrovascular accident—Bleomycin—melanoma	0.000869	0.0102	CcSEcCtD
Mirabegron—Back pain—Vemurafenib—melanoma	0.000819	0.00965	CcSEcCtD
Mirabegron—Vascular purpura—Temozolomide—melanoma	0.000803	0.00947	CcSEcCtD
Mirabegron—Purpura—Temozolomide—melanoma	0.000746	0.00879	CcSEcCtD
Mirabegron—Arthralgia—Vemurafenib—melanoma	0.000721	0.0085	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.000716	0.00844	CcSEcCtD
Mirabegron—Aspartate aminotransferase increased—Dactinomycin—melanoma	0.000715	0.00843	CcSEcCtD
Mirabegron—Infection—Vemurafenib—melanoma	0.000687	0.00809	CcSEcCtD
Mirabegron—Skin disorder—Vemurafenib—melanoma	0.000671	0.00791	CcSEcCtD
Mirabegron—Blood pressure increased—Docetaxel—melanoma	0.000658	0.00776	CcSEcCtD
Mirabegron—Breast disorder—Temozolomide—melanoma	0.000649	0.00765	CcSEcCtD
Mirabegron—Aspartate aminotransferase increased—Temozolomide—melanoma	0.000647	0.00763	CcSEcCtD
Mirabegron—Alanine aminotransferase increased—Temozolomide—melanoma	0.000634	0.00747	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00063	0.00742	CcSEcCtD
Mirabegron—Abdominal distension—Temozolomide—melanoma	0.000625	0.00737	CcSEcCtD
Mirabegron—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.000607	0.00715	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Vemurafenib—melanoma	0.000597	0.00703	CcSEcCtD
Mirabegron—Fatigue—Vemurafenib—melanoma	0.000596	0.00702	CcSEcCtD
Mirabegron—Neoplasm—Docetaxel—melanoma	0.000595	0.00701	CcSEcCtD
Mirabegron—Constipation—Vemurafenib—melanoma	0.000591	0.00696	CcSEcCtD
Mirabegron—Upper respiratory tract infection—Temozolomide—melanoma	0.000577	0.0068	CcSEcCtD
Mirabegron—Urinary tract infection—Carmustine—melanoma	0.000557	0.00656	CcSEcCtD
Mirabegron—Infestation NOS—Temozolomide—melanoma	0.000554	0.00653	CcSEcCtD
Mirabegron—Infestation—Temozolomide—melanoma	0.000554	0.00653	CcSEcCtD
Mirabegron—Stevens-Johnson syndrome—Temozolomide—melanoma	0.000549	0.00647	CcSEcCtD
Mirabegron—Urinary tract infection—Temozolomide—melanoma	0.000538	0.00634	CcSEcCtD
Mirabegron—Erythema multiforme—Dactinomycin—melanoma	0.00052	0.00612	CcSEcCtD
Mirabegron—Sinusitis—Temozolomide—melanoma	0.00052	0.00612	CcSEcCtD
Mirabegron—Connective tissue disorder—Carmustine—melanoma	0.000505	0.00596	CcSEcCtD
Mirabegron—Atrial fibrillation—Docetaxel—melanoma	0.000504	0.00594	CcSEcCtD
Mirabegron—Asthenia—Vemurafenib—melanoma	0.000496	0.00584	CcSEcCtD
Mirabegron—Urinary tract disorder—Temozolomide—melanoma	0.000491	0.00579	CcSEcCtD
Mirabegron—Pruritus—Vemurafenib—melanoma	0.000489	0.00576	CcSEcCtD
Mirabegron—Connective tissue disorder—Temozolomide—melanoma	0.000488	0.00576	CcSEcCtD
Mirabegron—Urethral disorder—Temozolomide—melanoma	0.000487	0.00574	CcSEcCtD
Mirabegron—Eye disorder—Carmustine—melanoma	0.000481	0.00567	CcSEcCtD
Mirabegron—Diarrhoea—Vemurafenib—melanoma	0.000473	0.00557	CcSEcCtD
Mirabegron—Erythema multiforme—Temozolomide—melanoma	0.00047	0.00554	CcSEcCtD
Mirabegron—Eye disorder—Temozolomide—melanoma	0.000465	0.00547	CcSEcCtD
Mirabegron—Cardiac disorder—Temozolomide—melanoma	0.000461	0.00544	CcSEcCtD
Mirabegron—Dizziness—Vemurafenib—melanoma	0.000457	0.00539	CcSEcCtD
Mirabegron—Rash—Vemurafenib—melanoma	0.000436	0.00513	CcSEcCtD
Mirabegron—Dermatitis—Vemurafenib—melanoma	0.000435	0.00513	CcSEcCtD
Mirabegron—Back pain—Carmustine—melanoma	0.000433	0.0051	CcSEcCtD
Mirabegron—Headache—Vemurafenib—melanoma	0.000433	0.0051	CcSEcCtD
Mirabegron—Breast disorder—Docetaxel—melanoma	0.000432	0.00509	CcSEcCtD
Mirabegron—Aspartate aminotransferase increased—Docetaxel—melanoma	0.00043	0.00507	CcSEcCtD
Mirabegron—Nasopharyngitis—Docetaxel—melanoma	0.000427	0.00504	CcSEcCtD
Mirabegron—Vision blurred—Carmustine—melanoma	0.000422	0.00497	CcSEcCtD
Mirabegron—Alanine aminotransferase increased—Docetaxel—melanoma	0.000421	0.00497	CcSEcCtD
Mirabegron—Back pain—Temozolomide—melanoma	0.000419	0.00493	CcSEcCtD
Mirabegron—Infection—Bleomycin—melanoma	0.000416	0.0049	CcSEcCtD
Mirabegron—Nausea—Vemurafenib—melanoma	0.00041	0.00484	CcSEcCtD
Mirabegron—Vision blurred—Temozolomide—melanoma	0.000408	0.00481	CcSEcCtD
Mirabegron—Infection—Dactinomycin—melanoma	0.000388	0.00457	CcSEcCtD
Mirabegron—Hypertension—Carmustine—melanoma	0.000387	0.00456	CcSEcCtD
Mirabegron—Palpitations—Temozolomide—melanoma	0.000382	0.00451	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Bleomycin—melanoma	0.000381	0.0045	CcSEcCtD
Mirabegron—Hypertension—Temozolomide—melanoma	0.000374	0.0044	CcSEcCtD
Mirabegron—Arthralgia—Temozolomide—melanoma	0.000368	0.00434	CcSEcCtD
Mirabegron—Infestation NOS—Docetaxel—melanoma	0.000368	0.00434	CcSEcCtD
Mirabegron—Infestation—Docetaxel—melanoma	0.000368	0.00434	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000366	0.00431	CcSEcCtD
Mirabegron—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000365	0.0043	CcSEcCtD
Mirabegron—Infection—Carmustine—melanoma	0.000363	0.00428	CcSEcCtD
Mirabegron—Dry mouth—Temozolomide—melanoma	0.00036	0.00425	CcSEcCtD
Mirabegron—Tachycardia—Carmustine—melanoma	0.000357	0.0042	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000356	0.00419	CcSEcCtD
Mirabegron—Infection—Temozolomide—melanoma	0.000351	0.00413	CcSEcCtD
Mirabegron—Skin disorder—Temozolomide—melanoma	0.000343	0.00404	CcSEcCtD
Mirabegron—Fatigue—Dactinomycin—melanoma	0.000337	0.00397	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Carmustine—melanoma	0.000333	0.00392	CcSEcCtD
Mirabegron—Urticaria—Bleomycin—melanoma	0.000333	0.00392	CcSEcCtD
Mirabegron—Rhinitis—Docetaxel—melanoma	0.000331	0.00391	CcSEcCtD
Mirabegron—Urinary tract disorder—Docetaxel—melanoma	0.000326	0.00385	CcSEcCtD
Mirabegron—Connective tissue disorder—Docetaxel—melanoma	0.000325	0.00383	CcSEcCtD
Mirabegron—Urethral disorder—Docetaxel—melanoma	0.000324	0.00382	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Temozolomide—melanoma	0.000322	0.00379	CcSEcCtD
Mirabegron—Gastrointestinal pain—Dactinomycin—melanoma	0.000319	0.00376	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Carmustine—melanoma	0.000316	0.00372	CcSEcCtD
Mirabegron—Erythema multiforme—Docetaxel—melanoma	0.000313	0.00368	CcSEcCtD
Mirabegron—Constipation—Carmustine—melanoma	0.000313	0.00368	CcSEcCtD
Mirabegron—Dyspepsia—Temozolomide—melanoma	0.000311	0.00366	CcSEcCtD
Mirabegron—Eye disorder—Docetaxel—melanoma	0.000309	0.00364	CcSEcCtD
Mirabegron—Abdominal pain—Dactinomycin—melanoma	0.000309	0.00364	CcSEcCtD
Mirabegron—Cardiac disorder—Docetaxel—melanoma	0.000307	0.00362	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Temozolomide—melanoma	0.000305	0.00359	CcSEcCtD
Mirabegron—Fatigue—Temozolomide—melanoma	0.000304	0.00359	CcSEcCtD
Mirabegron—Constipation—Temozolomide—melanoma	0.000302	0.00356	CcSEcCtD
Mirabegron—Asthenia—Bleomycin—melanoma	0.0003	0.00354	CcSEcCtD
Mirabegron—Gastrointestinal pain—Carmustine—melanoma	0.000299	0.00352	CcSEcCtD
Mirabegron—Pruritus—Bleomycin—melanoma	0.000296	0.00349	CcSEcCtD
Mirabegron—Abdominal pain—Carmustine—melanoma	0.000289	0.0034	CcSEcCtD
Mirabegron—Gastrointestinal pain—Temozolomide—melanoma	0.000289	0.0034	CcSEcCtD
Mirabegron—Urticaria—Temozolomide—melanoma	0.000281	0.00331	CcSEcCtD
Mirabegron—Asthenia—Dactinomycin—melanoma	0.00028	0.0033	CcSEcCtD
Mirabegron—Abdominal pain—Temozolomide—melanoma	0.000279	0.00329	CcSEcCtD
Mirabegron—Back pain—Docetaxel—melanoma	0.000278	0.00328	CcSEcCtD
Mirabegron—Diarrhoea—Dactinomycin—melanoma	0.000267	0.00315	CcSEcCtD
Mirabegron—Rash—Bleomycin—melanoma	0.000264	0.00311	CcSEcCtD
Mirabegron—Dermatitis—Bleomycin—melanoma	0.000264	0.00311	CcSEcCtD
Mirabegron—Asthenia—Carmustine—melanoma	0.000262	0.00309	CcSEcCtD
Mirabegron—Palpitations—Docetaxel—melanoma	0.000254	0.003	CcSEcCtD
Mirabegron—Asthenia—Temozolomide—melanoma	0.000253	0.00299	CcSEcCtD
Mirabegron—Diarrhoea—Carmustine—melanoma	0.00025	0.00295	CcSEcCtD
Mirabegron—Pruritus—Temozolomide—melanoma	0.00025	0.00294	CcSEcCtD
Mirabegron—Nausea—Bleomycin—melanoma	0.000249	0.00293	CcSEcCtD
Mirabegron—Hypertension—Docetaxel—melanoma	0.000248	0.00293	CcSEcCtD
Mirabegron—Rash—Dactinomycin—melanoma	0.000246	0.0029	CcSEcCtD
Mirabegron—Arthralgia—Docetaxel—melanoma	0.000245	0.00289	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000243	0.00287	CcSEcCtD
Mirabegron—Dizziness—Carmustine—melanoma	0.000242	0.00285	CcSEcCtD
Mirabegron—Diarrhoea—Temozolomide—melanoma	0.000242	0.00285	CcSEcCtD
Mirabegron—Dry mouth—Docetaxel—melanoma	0.00024	0.00282	CcSEcCtD
Mirabegron—Dizziness—Temozolomide—melanoma	0.000234	0.00275	CcSEcCtD
Mirabegron—Infection—Docetaxel—melanoma	0.000233	0.00275	CcSEcCtD
Mirabegron—Nausea—Dactinomycin—melanoma	0.000232	0.00273	CcSEcCtD
Mirabegron—Rash—Carmustine—melanoma	0.00023	0.00272	CcSEcCtD
Mirabegron—Dermatitis—Carmustine—melanoma	0.00023	0.00271	CcSEcCtD
Mirabegron—Tachycardia—Docetaxel—melanoma	0.000229	0.0027	CcSEcCtD
Mirabegron—Headache—Carmustine—melanoma	0.000229	0.0027	CcSEcCtD
Mirabegron—Skin disorder—Docetaxel—melanoma	0.000228	0.00269	CcSEcCtD
Mirabegron—Rash—Temozolomide—melanoma	0.000223	0.00262	CcSEcCtD
Mirabegron—Dermatitis—Temozolomide—melanoma	0.000222	0.00262	CcSEcCtD
Mirabegron—Headache—Temozolomide—melanoma	0.000221	0.00261	CcSEcCtD
Mirabegron—Nausea—Carmustine—melanoma	0.000217	0.00256	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Docetaxel—melanoma	0.000214	0.00252	CcSEcCtD
Mirabegron—Nausea—Temozolomide—melanoma	0.00021	0.00247	CcSEcCtD
Mirabegron—Dyspepsia—Docetaxel—melanoma	0.000207	0.00244	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Docetaxel—melanoma	0.000203	0.00239	CcSEcCtD
Mirabegron—Fatigue—Docetaxel—melanoma	0.000202	0.00239	CcSEcCtD
Mirabegron—Constipation—Docetaxel—melanoma	0.000201	0.00237	CcSEcCtD
Mirabegron—Gastrointestinal pain—Docetaxel—melanoma	0.000192	0.00226	CcSEcCtD
Mirabegron—Abdominal pain—Docetaxel—melanoma	0.000186	0.00219	CcSEcCtD
Mirabegron—Asthenia—Docetaxel—melanoma	0.000169	0.00199	CcSEcCtD
Mirabegron—Pruritus—Docetaxel—melanoma	0.000166	0.00196	CcSEcCtD
Mirabegron—Diarrhoea—Docetaxel—melanoma	0.000161	0.00189	CcSEcCtD
Mirabegron—Dizziness—Docetaxel—melanoma	0.000155	0.00183	CcSEcCtD
Mirabegron—Rash—Docetaxel—melanoma	0.000148	0.00175	CcSEcCtD
Mirabegron—Dermatitis—Docetaxel—melanoma	0.000148	0.00174	CcSEcCtD
Mirabegron—Headache—Docetaxel—melanoma	0.000147	0.00173	CcSEcCtD
Mirabegron—Nausea—Docetaxel—melanoma	0.00014	0.00164	CcSEcCtD
Mirabegron—BCHE—Metabolism of proteins—MMP2—melanoma	1.17e-05	0.00038	CbGpPWpGaD
Mirabegron—BCHE—Neuronal System—HRAS—melanoma	1.16e-05	0.000379	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—PIK3CB—melanoma	1.16e-05	0.000379	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—PDGFRA—melanoma	1.16e-05	0.000376	CbGpPWpGaD
Mirabegron—BCHE—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.16e-05	0.000376	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.15e-05	0.000374	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—PRKCA—melanoma	1.14e-05	0.000373	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—ITGB3—melanoma	1.14e-05	0.000373	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—CYP1B1—melanoma	1.14e-05	0.000372	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PHGDH—melanoma	1.14e-05	0.000372	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—LUM—melanoma	1.14e-05	0.000372	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—HS3ST5—melanoma	1.14e-05	0.000371	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—SPP1—melanoma	1.12e-05	0.000365	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—HPSE—melanoma	1.12e-05	0.000364	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—MAP2K2—melanoma	1.12e-05	0.000364	CbGpPWpGaD
Mirabegron—ALB—Transmembrane transport of small molecules—ABCB1—melanoma	1.12e-05	0.000364	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—CXCL8—melanoma	1.12e-05	0.000364	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—RAC1—melanoma	1.1e-05	0.000359	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CUBN—melanoma	1.1e-05	0.000358	CbGpPWpGaD
Mirabegron—ALB—Platelet activation, signaling and aggregation—VEGFA—melanoma	1.08e-05	0.000352	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—LUM—melanoma	1.07e-05	0.00035	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PHGDH—melanoma	1.07e-05	0.00035	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—ABCB1—melanoma	1.07e-05	0.000349	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—IL2—melanoma	1.07e-05	0.000348	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—MMP1—melanoma	1.07e-05	0.000347	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—TERT—melanoma	1.06e-05	0.000346	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	1.06e-05	0.000346	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—RAC1—melanoma	1.06e-05	0.000346	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—SDHD—melanoma	1.06e-05	0.000345	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—BSG—melanoma	1.06e-05	0.000345	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CSPG4—melanoma	1.06e-05	0.000345	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—HPSE—melanoma	1.05e-05	0.000343	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—CDK2—melanoma	1.05e-05	0.000341	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CUBN—melanoma	1.03e-05	0.000337	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—GPAM—melanoma	1.03e-05	0.000335	CbGpPWpGaD
Mirabegron—ALB—Platelet activation, signaling and aggregation—MAPK3—melanoma	1.02e-05	0.000333	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—HIF1A—melanoma	1.02e-05	0.000331	CbGpPWpGaD
Mirabegron—BCHE—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.01e-05	0.000328	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	1.01e-05	0.000328	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—SDHD—melanoma	9.99e-06	0.000326	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CSPG4—melanoma	9.99e-06	0.000326	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—BSG—melanoma	9.99e-06	0.000326	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PLA2G6—melanoma	9.97e-06	0.000325	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—PRKCA—melanoma	9.86e-06	0.000321	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	9.78e-06	0.000319	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—ERCC2—melanoma	9.78e-06	0.000319	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—KDR—melanoma	9.73e-06	0.000317	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—FN1—melanoma	9.73e-06	0.000317	CbGpPWpGaD
Mirabegron—ALB—Platelet activation, signaling and aggregation—MAPK1—melanoma	9.72e-06	0.000317	CbGpPWpGaD
Mirabegron—BCHE—Metabolism of proteins—CXCL8—melanoma	9.68e-06	0.000315	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—GPAM—melanoma	9.68e-06	0.000315	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—NOS2—melanoma	9.61e-06	0.000313	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	9.57e-06	0.000312	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	9.57e-06	0.000312	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—ABCB1—melanoma	9.4e-06	0.000306	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—FN1—melanoma	9.36e-06	0.000305	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—PIK3CG—melanoma	9.31e-06	0.000303	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—EGF—melanoma	9.2e-06	0.0003	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—NOTCH1—melanoma	9.16e-06	0.000299	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	9.11e-06	0.000297	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	9.04e-06	0.000294	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—CD80—melanoma	8.98e-06	0.000292	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—PIK3CG—melanoma	8.96e-06	0.000292	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—KIT—melanoma	8.96e-06	0.000292	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—APC—melanoma	8.96e-06	0.000292	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—NRAS—melanoma	8.96e-06	0.000292	CbGpPWpGaD
Mirabegron—ALB—Metabolism—VCAN—melanoma	8.95e-06	0.000292	CbGpPWpGaD
Mirabegron—BCHE—Metabolism of proteins—CTNNB1—melanoma	8.93e-06	0.000291	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—EGF—melanoma	8.86e-06	0.000289	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PLA2G6—melanoma	8.73e-06	0.000284	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—PRKCA—melanoma	8.65e-06	0.000282	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PLCB4—melanoma	8.62e-06	0.000281	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—MAPK3—melanoma	8.58e-06	0.00028	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—ERCC2—melanoma	8.58e-06	0.00028	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—IGF1—melanoma	8.52e-06	0.000278	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	8.47e-06	0.000276	CbGpPWpGaD
Mirabegron—ALB—Platelet activation, signaling and aggregation—PIK3CA—melanoma	8.44e-06	0.000275	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—BRAF—melanoma	8.42e-06	0.000274	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	8.31e-06	0.000271	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PLA2G6—melanoma	8.23e-06	0.000268	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—IGF1—melanoma	8.21e-06	0.000267	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—PIK3CD—melanoma	8.18e-06	0.000267	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—PPARG—melanoma	8.18e-06	0.000266	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—MAPK1—melanoma	8.17e-06	0.000266	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—EGFR—melanoma	8.16e-06	0.000266	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—SLC6A11—melanoma	8.11e-06	0.000264	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PIP4K2A—melanoma	8.11e-06	0.000264	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	8.1e-06	0.000264	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	8.04e-06	0.000262	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—MAP2K1—melanoma	7.93e-06	0.000258	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—MTAP—melanoma	7.89e-06	0.000257	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—PIK3CD—melanoma	7.88e-06	0.000257	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—VCAN—melanoma	7.84e-06	0.000256	CbGpPWpGaD
Mirabegron—ADRB3—GPCR downstream signaling—PIK3CA—melanoma	7.8e-06	0.000254	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—PIK3CG—melanoma	7.72e-06	0.000252	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—KRAS—melanoma	7.71e-06	0.000251	CbGpPWpGaD
Mirabegron—ALB—Metabolism—CYP17A1—melanoma	7.55e-06	0.000246	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—FGF2—melanoma	7.54e-06	0.000246	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—PPARG—melanoma	7.46e-06	0.000243	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	7.45e-06	0.000243	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—VCAN—melanoma	7.39e-06	0.000241	CbGpPWpGaD
Mirabegron—ALB—Metabolism—GNA11—melanoma	7.13e-06	0.000232	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—PIK3CB—melanoma	7.13e-06	0.000232	CbGpPWpGaD
Mirabegron—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	7.11e-06	0.000232	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—PIK3CA—melanoma	7.09e-06	0.000231	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—MDM2—melanoma	7.06e-06	0.00023	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PHGDH—melanoma	7.03e-06	0.000229	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—LUM—melanoma	7.03e-06	0.000229	CbGpPWpGaD
Mirabegron—ALB—Metabolism—FASN—melanoma	6.98e-06	0.000227	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—ERBB2—melanoma	6.96e-06	0.000227	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—HPSE—melanoma	6.89e-06	0.000225	CbGpPWpGaD
Mirabegron—ALB—Platelet activation, signaling and aggregation—AKT1—melanoma	6.89e-06	0.000224	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—PIK3CB—melanoma	6.87e-06	0.000224	CbGpPWpGaD
Mirabegron—ALB—Metabolism—SLC5A5—melanoma	6.87e-06	0.000224	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—PIK3CD—melanoma	6.79e-06	0.000221	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	6.79e-06	0.000221	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—PIK3CG—melanoma	6.78e-06	0.000221	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CUBN—melanoma	6.77e-06	0.00022	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—ALB—melanoma	6.7e-06	0.000218	CbGpPWpGaD
Mirabegron—ALB—Metabolism—GNAQ—melanoma	6.63e-06	0.000216	CbGpPWpGaD
Mirabegron—ALB—Metabolism—CD44—melanoma	6.63e-06	0.000216	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CYP17A1—melanoma	6.62e-06	0.000216	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—CXCL8—melanoma	6.6e-06	0.000215	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—HRAS—melanoma	6.56e-06	0.000214	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—IL2—melanoma	6.55e-06	0.000213	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—PPARG—melanoma	6.54e-06	0.000213	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—BSG—melanoma	6.53e-06	0.000213	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—SDHD—melanoma	6.53e-06	0.000213	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CSPG4—melanoma	6.53e-06	0.000213	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	6.49e-06	0.000212	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—CDKN1B—melanoma	6.44e-06	0.00021	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—PTGS2—melanoma	6.43e-06	0.00021	CbGpPWpGaD
Mirabegron—ADRB3—GPCR downstream signaling—AKT1—melanoma	6.37e-06	0.000208	CbGpPWpGaD
Mirabegron—ALB—Metabolism—CYP1B1—melanoma	6.36e-06	0.000207	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GPAM—melanoma	6.33e-06	0.000206	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—CASP3—melanoma	6.32e-06	0.000206	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—IL2—melanoma	6.31e-06	0.000205	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—IL6—melanoma	6.28e-06	0.000204	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—GNA11—melanoma	6.25e-06	0.000204	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CYP17A1—melanoma	6.24e-06	0.000203	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—CCND1—melanoma	6.15e-06	0.0002	CbGpPWpGaD
Mirabegron—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	6.13e-06	0.0002	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—FASN—melanoma	6.12e-06	0.000199	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—CTNNB1—melanoma	6.09e-06	0.000198	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—SLC5A5—melanoma	6.02e-06	0.000196	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—MMP9—melanoma	5.97e-06	0.000194	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—PIK3CD—melanoma	5.96e-06	0.000194	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—CDKN1A—melanoma	5.95e-06	0.000194	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—PTEN—melanoma	5.93e-06	0.000193	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—PIK3CB—melanoma	5.92e-06	0.000193	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—NFKB1—melanoma	5.91e-06	0.000192	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—GNA11—melanoma	5.89e-06	0.000192	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—ALB—melanoma	5.88e-06	0.000192	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—PTGS2—melanoma	5.87e-06	0.000191	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—GNAQ—melanoma	5.81e-06	0.000189	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CD44—melanoma	5.81e-06	0.000189	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—AKT1—melanoma	5.79e-06	0.000189	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—FASN—melanoma	5.76e-06	0.000188	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—SLC5A5—melanoma	5.67e-06	0.000185	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—PTEN—melanoma	5.61e-06	0.000183	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CYP1B1—melanoma	5.57e-06	0.000181	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—VEGFA—melanoma	5.57e-06	0.000181	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—NRAS—melanoma	5.5e-06	0.000179	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—GNAQ—melanoma	5.48e-06	0.000178	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CD44—melanoma	5.48e-06	0.000178	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PLA2G6—melanoma	5.38e-06	0.000175	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—VEGFA—melanoma	5.36e-06	0.000175	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—STAT3—melanoma	5.31e-06	0.000173	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—NRAS—melanoma	5.29e-06	0.000172	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—MAPK3—melanoma	5.27e-06	0.000172	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CYP1B1—melanoma	5.25e-06	0.000171	CbGpPWpGaD
Mirabegron—ALB—Metabolism—ABCB1—melanoma	5.24e-06	0.000171	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—PIK3CB—melanoma	5.19e-06	0.000169	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—PTGS2—melanoma	5.15e-06	0.000168	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—PTEN—melanoma	5.11e-06	0.000167	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—MAPK3—melanoma	5.07e-06	0.000165	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—MAPK1—melanoma	5.01e-06	0.000163	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—MYC—melanoma	4.93e-06	0.000161	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—VCAN—melanoma	4.83e-06	0.000157	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—MAPK1—melanoma	4.82e-06	0.000157	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—EGFR—melanoma	4.82e-06	0.000157	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PRKCA—melanoma	4.82e-06	0.000157	CbGpPWpGaD
Mirabegron—ALB—Metabolism—ERCC2—melanoma	4.78e-06	0.000156	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—KRAS—melanoma	4.73e-06	0.000154	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—KRAS—melanoma	4.56e-06	0.000148	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—PTEN—melanoma	4.49e-06	0.000146	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—PIK3CA—melanoma	4.35e-06	0.000142	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—ABCB1—melanoma	4.32e-06	0.000141	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PRKCA—melanoma	4.22e-06	0.000138	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—TP53—melanoma	4.21e-06	0.000137	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—ERCC2—melanoma	4.19e-06	0.000136	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—PIK3CA—melanoma	4.19e-06	0.000136	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CYP17A1—melanoma	4.08e-06	0.000133	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—TP53—melanoma	4.05e-06	0.000132	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—HRAS—melanoma	4.02e-06	0.000131	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PRKCA—melanoma	3.98e-06	0.00013	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.96e-06	0.000129	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—ERCC2—melanoma	3.95e-06	0.000129	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—HRAS—melanoma	3.87e-06	0.000126	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GNA11—melanoma	3.85e-06	0.000125	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PIK3CG—melanoma	3.77e-06	0.000123	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—FASN—melanoma	3.77e-06	0.000123	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—IL6—melanoma	3.71e-06	0.000121	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—SLC5A5—melanoma	3.71e-06	0.000121	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PPARG—melanoma	3.64e-06	0.000119	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—PIK3CA—melanoma	3.61e-06	0.000118	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GNAQ—melanoma	3.58e-06	0.000117	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CD44—melanoma	3.58e-06	0.000117	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—AKT1—melanoma	3.55e-06	0.000116	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CYP1B1—melanoma	3.43e-06	0.000112	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—AKT1—melanoma	3.42e-06	0.000111	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PIK3CD—melanoma	3.32e-06	0.000108	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PIK3CG—melanoma	3.31e-06	0.000108	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PPARG—melanoma	3.19e-06	0.000104	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—PIK3CA—melanoma	3.17e-06	0.000103	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PIK3CG—melanoma	3.12e-06	0.000102	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PPARG—melanoma	3.01e-06	9.8e-05	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—AKT1—melanoma	2.95e-06	9.6e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PIK3CD—melanoma	2.91e-06	9.47e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PIK3CB—melanoma	2.89e-06	9.42e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—ALB—melanoma	2.87e-06	9.35e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PTGS2—melanoma	2.87e-06	9.33e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ABCB1—melanoma	2.83e-06	9.21e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PIK3CD—melanoma	2.74e-06	8.92e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—ALB—melanoma	2.7e-06	8.81e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PRKCA—melanoma	2.6e-06	8.47e-05	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—AKT1—melanoma	2.59e-06	8.42e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ERCC2—melanoma	2.58e-06	8.4e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PIK3CB—melanoma	2.53e-06	8.25e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PTGS2—melanoma	2.51e-06	8.18e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PTEN—melanoma	2.5e-06	8.14e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PIK3CB—melanoma	2.39e-06	7.78e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PTGS2—melanoma	2.37e-06	7.71e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PTEN—melanoma	2.19e-06	7.13e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PTEN—melanoma	2.06e-06	6.72e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PIK3CG—melanoma	2.04e-06	6.64e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PPARG—melanoma	1.97e-06	6.41e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PIK3CD—melanoma	1.79e-06	5.83e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ALB—melanoma	1.77e-06	5.76e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PIK3CA—melanoma	1.76e-06	5.74e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PIK3CB—melanoma	1.56e-06	5.09e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PTGS2—melanoma	1.55e-06	5.04e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PIK3CA—melanoma	1.54e-06	5.03e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PIK3CA—melanoma	1.46e-06	4.74e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—AKT1—melanoma	1.44e-06	4.69e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PTEN—melanoma	1.35e-06	4.39e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—AKT1—melanoma	1.26e-06	4.11e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—AKT1—melanoma	1.19e-06	3.87e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PIK3CA—melanoma	9.52e-07	3.1e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—AKT1—melanoma	7.77e-07	2.53e-05	CbGpPWpGaD
